Volume 60, Issue 2, Pages (August 2011)

Slides:

Advertisements

Similar presentations

Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator—the EVADEF.

Advertisements

Volume 60, Issue 4, Pages (October 2011)

Volume 52, Issue 1, Pages (July 2007)

Volume 60, Issue 6, Pages (December 2011)

Volume 172, Issue 6, Pages (December 2004)

Pascal Rischmann European Urology Supplements

Volume 71, Issue 2, Pages (February 2017)

Volume 68, Issue 2, Pages (August 2015)

Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype Solene-Florence Kammerer-Jacquet,

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis Maria I. Carlo, Darren R.

Volume 44, Issue 6, Pages (December 2003)

Volume 58, Issue 4, Pages (October 2010)

Volume 55, Issue 2, Pages (February 2009)

Volume 60, Issue 2, Pages (August 2011)

Volume 42, Issue 2, Pages (August 2002)

Volume 60, Issue 6, Pages (December 2011)

Volume 51, Issue 1, Pages (January 2007)

Volume 63, Issue 1, Pages (January 2013)

Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Histologic Grading of Noninvasive Papillary Urothelial Neoplasms

Volume 54, Issue 4, Pages (October 2008)

Volume 68, Issue 1, Pages (July 2015)

Volume 71, Issue 2, Pages (February 2017)

Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension Laurent Savale, MD, PhD, Jérôme Le Pavec, MD, PhD,

Long-Term Outcome and Valve Surgery for Infective Endocarditis in the Systematic Analysis of a Community Study Lauriane Pericart, MD, Laurent Fauchier,

Volume 66, Issue 2, Pages (August 2014)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 74, Issue 4, Pages (October 2018)

Volume 54, Issue 4, Pages (October 2008)

Volume 52, Issue 5, Pages (November 2007)

Volume 68, Issue 1, Pages 5-7 (July 2015)

Volume 55, Issue 2, Pages (February 2009)

Volume 52, Issue 1, Pages (July 2007)

Volume 57, Issue 4, Pages (April 2010)

Volume 66, Issue 5, Pages (November 2014)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Volume 61, Issue 6, Pages (June 2012)

Volume 53, Issue 2, Pages (February 2008)

Volume 74, Issue 3, Pages (September 2018)

Volume 52, Issue 2, Pages (August 2007)

Volume 42, Issue 2, Pages (August 2002)

Volume 58, Issue 4, Pages (October 2010)

Volume 54, Issue 4, Pages (October 2008)

Volume 61, Issue 2, Pages (February 2012)

Volume 59, Issue 1, Pages (January 2011)

Volume 56, Issue 5, Pages (November 2009)

Tyrosine Kinase Inhibitors in Clinical Practice: Patient Selection

Volume 50, Issue 3, Pages (September 2006)

Volume 50, Issue 2, Pages (August 2006)

Volume 51, Issue 2, Pages (February 2007)

Volume 52, Issue 6, Pages (December 2007)

What's New in Prostate Cancer: Highlights from Urologic and Oncologic Congresses in 2006 Michel Soulié, Nicolas Mottet, Laurent Salomon, Jacques Irani,

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Volume 54, Issue 4, Pages (October 2008)

Sergio Bracarda European Urology Supplements

Volume 51, Issue 6, Pages (June 2007)

Helping patients make informed decisions

European Association of Urology Guidelines for Systemic Therapy in Metastatic Renal Cell Carcinoma: What is Recommended and Why? Jean-Jacques Patard

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Annika Berntsen, Poul F. Geertsen, Inge Marie Svane European Urology

Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection Emilie Perrot, MD, Benoit Guibert, MD, Pierre Mulsant,

Is Pneumonectomy After Induction Chemotherapy for Non-small Cell Lung Cancer a Reasonable Procedure? A Multicenter Retrospective Study of 228 Cases Yoann.

Increased risk of solid renal tumors in lithium-treated patients

Jan Roigas European Urology Supplements

Propensity Score Analysis Comparing Videothoracoscopic Lobectomy With Thoracotomy: A French Nationwide Study Pierre-Benoit Pagès, MD, PhD, Jean-Philippe.

Pathology and Molecular Pathogenesis of Renal Cell Carcinoma

Volume 54, Issue 1, Pages (July 2008)

Update on the Medical Treatment of Metastatic Renal Cell Carcinoma

Prognostic factors and long-term results after thymoma resection: A series of 307 patients Jean-François Regnard, MDa, Pierre Magdeleinat, MDa, Christian.

Presentation transcript:

Volume 60, Issue 2, Pages 366-373 (August 2011) Renal Cell Carcinoma (RCC) in Patients With End-Stage Renal Disease Exhibits Many Favourable Clinical, Pathologic, and Outcome Features Compared With RCC in the General Population Yann Neuzillet, Xavier Tillou, Romain Mathieu, Jean-Alexandre Long, Marc Gigante, Philippe Paparel, Laura Poissonnier, Hervé Baumert, Bernard Escudier, Hervé Lang, Nathalie Rioux-Leclercq, Pierre Bigot, Jean-Christophe Bernhard, Laurence Albiges, Laurence Bastien, Jacques Petit, Fabien Saint, Franck Bruyere, Jean-Michel Boutin, Nicolas Brichart, Georges Karam, Julien Branchereau, Jean- Marie Ferriere, Hervé Wallerand, Sébastien Barbet, Hicham Elkentaoui, Jacques Hubert, Benoit Feuillu, Pierre-Etienne Theveniaud, Arnauld Villers, Laurent Zini, Aurélien Descazeaux, Morgan Roupret, Benoit Barrou, Karim Fehri, Thierry Lebret, Jacques Tostain, Jean- Etienne Terrier, Nicolas Terrier, Lucille Martin, Fabrice Dugardin, Ismaël Galliot, Frédéric Staerman, Marie-Dominique Azemar, Jacques Irani, Baptiste Tisserand, Marc-Olivier Timsit, Federico Sallusto, Pascal Rischmann, Laurent Guy, Antoine Valeri, Charles Deruelle, Abdel-Rahmène Azzouzi, Denis Chautard, Arnaud Mejean, Laurent Salomon, Jérôme Rigaud, Christian Pfister, Michel Soulié, François Kleinclauss, Lionel Badet, Jean-Jacques Patard European Urology Volume 60, Issue 2, Pages 366-373 (August 2011) DOI: 10.1016/j.eururo.2011.02.035 Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 1 Comparison of renal cell carcinoma (RCC)–specific survival time for end-stage renal disease (ESRD) and non-ESRD patients. European Urology 2011 60, 366-373DOI: (10.1016/j.eururo.2011.02.035) Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 2 Comparison of renal cell carcinoma (RCC)–specific survival time stratified by histologic subtype (a) for clear cell RCCs arising in end-stage renal disease (ESRD) and non-ESRD patients and (b) for papillary RCCs arising in ESRD and non-ESRD patients. European Urology 2011 60, 366-373DOI: (10.1016/j.eururo.2011.02.035) Copyright © 2011 European Association of Urology Terms and Conditions